Note: Ingredients listed on restricted chemical lists
EC/CAS
7727-37-9
Name of the chemical
Nitrogen N2
Concentration
N/A
General Information
Revision date
2019-10-31
Product name
INOmax
Product Synonyms
INOmax® (800 ppm) * Nitric Oxide (0.08%) Blended with Nitrogen (99.92%) * INOflo®
supplier name
Ikaria Australia Pty Ltd
Manufacturer Name
Mallinckrodt Manufacturing LLC
Icons in SDS
Company Information
company name
Ikaria Australia Pty Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
Brands.SDS@mnk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified. Eealth hazards Specific target organ toxicity following single Category 1 (blood, lung) exposure
Environmental hazards
Not classified. Label elements, including precautionary statements Eazard symbol(s) Gas cylinder
Signal word
Warning Eazard statement(s) Contains gas under pressure; may explode if heated.
Prevention
Do not handle until all safety precautions have been read and understood. Keep container tightly closed. Use only outdoors or in a well-ventilated area. Wear respiratory protection.
Response
IF exposed: Call a POISON CENTRE or doctor/physician.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
May displace oxygen and cause rapid suffocation. Exposure to rapidly expanding gas or vapourizing liquid may cause frostbite ("cold burn"). Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. Those with pre-existing heart, lung, or blood disorders may be more susceptible to the symptoms of asphyxia. Nitric oxide converts to nitrogen dioxide when exposed to air. Used in the treatment of prescribed medical disorders. Administration of this gas mixture may be hazardous or contraindicated. Use only under the supervision of an experienced licensed practitioner familiar with the indications for use, dosages, methods, hazards, contraindications, and side effects.
Additional information
The hazard warnings associated with this product are based on the individual ingredients included in the finished dosage form of the pharmaceutical product. The supplied package insert (approved labeling) provides the necessary drug safety information. All Mallinckrodt finished products are labeled in compliance with the requirements of the Food and Drug Administration (FDA) and must be used in the prescribed manner. Each package of the finished pharmaceutical product is supplied with a package insert (approved labeling) which provides necessary drug safety information.
